Unapproved New Drugs
Similar Posts
Olympus Issues Voluntary Labeling Update for Bronchoscopes Used with Laser Therapy Equipment
CENTER VALLEY, Pa., (October 31, 2025) – Olympus Corporation has announced a voluntary, global medical device corrective action to provide further clarification on the safe and effective use of bronchoscopes with laser therapy, argon plasma coagulation or high-frequency cauterization equipment durinPatient-Focused Drug Development
The OCE PFDD program fosters collaboration between FDA centers and external stakeholders involved in patient outcomes research in cancer populations.Health and Natural Beauty USA Corp. – 700187 – 07/28/2025
CGMP/Finished Pharmaceuticals/AdulteratedUnichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling
08/27/2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, to the consumer level. The Cyclobenzaprine 10mg (90ct) label was inadvertently placed on a bottle containing MeloxicamAvoiding Products Contaminated with Hidden Ingredients
Many products claiming to help with health issues hide dangerous drug ingredients. Get informed about how to avoid contaminated products and their hidden ingredients.Products Containing 7-OH Can Cause Serious Harm
The FDA recommends that consumers avoid 7-OH products, including foods, dietary supplements and those claiming to treat an ailment or disorder. 7-OH is not approved as a drug by the FDA.